Director, Commercial Data, Advanced Analytics & Forecasting (Fully Remote)

REGENXBIO Inc.; United States; Remote; USD 196,000 - 265,000; Full time

Benefits offered by this job

Annual bonus

Education assistance

Retirement plan

Stock options

Paid caregiver leave

Summer hours

Comprehensive benefits package

Job summary

REGENXBIO Inc. is seeking a senior leader to drive commercial data, analytics, and forecasting across launches in the United States. You will design measurement frameworks linking market signals to patient outcomes and business results.

You will manage data sources and build dashboards to support recurring reviews, guiding strategic decisions with advanced analytics and cross-functional collaboration.

Qualifications

• 10+ years in commercial analytics, data science, or forecasting in pharma/biotech.
• Advanced SQL and hands-on Python, R, SAS, or Alteryx.
• Experience with US product launches and patient-based forecasting.

Responsibilities

• Lead commercial data, advanced analytics, and forecasting functions.
• Design measurement frameworks connecting market, customer, and business outcomes.
• Manage data sources and develop dashboards for recurring reviews.

Skills

Advanced SQL

Python/R/SAS/Alteryx

10+ years in analytics

Forecasting in pharma/biotech

Tools

SQL

Python

R

SAS

Alteryx

Job description

• Lead commercial data, advanced analytics, and forecasting functions.
• Design measurement frameworks connecting market, customer, and business outcomes.
• Manage data sources and develop dashboards for recurring reviews.

Qualifications:

• 10+ years in commercial analytics, data science, or forecasting in pharma/biotech.
• Advanced SQL and hands-on Python, R, SAS, or Alteryx.
• Experience with US product launches and patient-based forecasting.
• Estimated salary range $196,000-$265,000 annually.
• Annual bonus, education assistance, retirement plan, stock options, and paid caregiver leave.
• Summer hours and comprehensive benefits package.

REGENXBIO

REGENXBIO is a gene therapy company advancing a pipeline of treatments for rare and retinal diseases. The culture is purpose-driven and collaborative, with a focus on making a meaningful difference for patients and their families.